WELLIA-R Tablet is a specialized nutraceutical designed to support onco-wellness, particularly focusing on brain health and overall wellness during cancer treatment. Each tablet contains 400mg of Khunduru Ghana, derived from Boswellia Strata Extract (25%), renowned for its potent anti-inflammatory and neuroprotective properties. Boswellia Serrata Extract, rich in boswellic acids, forms the cornerstone of WELLIA-R's formulation.

Ingredients Health Benefits:

Boswellia Serrata Extract: Known for balancing cerebral inflammatory responses and protecting brain tissue. It aids in reducing cerebral edema, potentiating apoptosis, and reactivating tumor suppressor genes. Additionally, it enhances immune function, delays hypersensitivity reactions, and inhibits the nuclear factor-kappa pathway, contributing to overall wellness during cancer treatment.

Key Features

Natural Ingredients: Formulated with high-quality, natural ingredients to support overall wellness.

Onco-Wellness Focus: Specifically designed to cater to the unique needs of individuals undergoing cancer treatment or in remission.

Scientifically Supported: Backed by research and studies showcasing its efficacy in supporting brain health and overall wellness.

Optimal Dosage: Each tablet contains a precise dosage of ingredients to ensure maximum effectiveness.

Safe and Trusted: Manufactured in a state-of-the-art facility, ensuring safety and quality standards are met.


Balanced Cerebral Inflammatory Response: WELLIA-R aids in balancing cerebral inflammatory responses, crucial for brain health during cancer treatment.

Brain Tissue Protection: The formulation includes ingredients that protect brain tissue, minimizing potential damage caused by treatment or underlying conditions.

Reduced Cerebral Edema: Studies have shown that supplementation with WELLIA-R leads to a significant reduction in cerebral edema, improving overall brain function.

Enhanced Immune Response: Boosts cell-mediated and humoral antibody synthesis, supporting the immune system during cancer treatment.

Supports Tumor Suppressor Genes: Helps demethylate and reactivate putative tumor suppressor genes, potentially aiding in cancer management.

Inhibition of Nuclear Factor-Kappa Pathway: WELLIA-R inhibits the nuclear factor-kappa pathway, which plays a role in inflammation and cancer progression.

Delay in Type I Hypersensitivity: Delays type I hypersensitivity reactions, providing relief from allergic responses often seen during cancer treatment.


Store WELLIA-R tablets in a cool, dry place away from direct sunlight. Keep the container tightly closed to prevent moisture and air exposure, which can affect the integrity of the ingredients.


Take 1 tablet twice daily, or as directed by a healthcare professional. For best results, take consistently as part of a balanced diet and healthy lifestyle.


WELLIA-R tablets come in a convenient packaging of 2*15 (30 tablets), ensuring an ample supply for continued support.